Rabies virus l protein b cell epitope polypeptides, monoclonal antibodies and uses

CN122213201APending Publication Date: 2026-06-16LONGHU LAB
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
LONGHU LAB
Filing Date
2026-05-09
Publication Date
2026-06-16

Smart Images

  • Figure CN122213201A_ABST
    Figure CN122213201A_ABST
Patent Text Reader

Abstract

The application discloses a rabies virus L protein B cell epitope polypeptide, a monoclonal antibody and application, and belongs to the technical field of biotechnology.A new type of B cell linear epitope of a rabies virus L protein is identified and disclosed for the first time, and the amino acid sequence is PLSRGEIFSIPQKIPA.The application further provides a monoclonal antibody against the rabies virus L protein, the monoclonal antibody can specifically recognize the B cell epitope, and provides an important tool for function research and expression detection of the rabies virus L protein.Meanwhile, the application determines key amino acid residues in the B cell epitope through an alanine scanning mutation technology, and provides a basis for in-depth understanding of an antigen-antibody interaction mechanism.In summary, the identified B cell epitope and the provided monoclonal antibody against the rabies virus L protein lay a solid technical foundation for development of a broad-spectrum rabies serological diagnostic reagent and a new type of vaccine (such as an epitope vaccine).
Need to check novelty before this filing date? Find Prior Art